We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Fewer Than One Third of New Drugs are of High Therapeutic Value, Study Finds
Fewer Than One Third of New Drugs are of High Therapeutic Value, Study Finds
Fewer than a third of new drugs approved by the FDA and the European Medicines Agency over the past decade had high therapeutic value, a team of U.S. and Swiss researchers found.